Company Filing History:
Years Active: 2008
Title: Yvan LeHuerou: Innovator in Pharmaceutical Chemistry
Introduction
Yvan LeHuerou is a notable inventor based in Boulder, Colorado, recognized for his contributions to pharmaceutical chemistry. He has developed innovative compounds that have significant implications for the treatment of various mental health disorders.
Latest Patents
LeHuerou holds a patent for "Piperazine substituted aryl benzodiazepines." This patent describes compounds that include a variety of aromatic rings and functional groups, which are designed to act as antagonists of the dopamine D2 receptor. These compounds are particularly relevant for the treatment of psychosis and bipolar disorders, showcasing their potential in pharmaceutical formulations.
Career Highlights
Yvan LeHuerou has made significant strides in his career, particularly through his work at Eli Lilly and Company. His research focuses on developing new therapeutic agents that can improve mental health outcomes for patients.
Collaborations
LeHuerou has collaborated with esteemed colleagues such as Thomas Daniel Aicher and Zhaogen Chen. These partnerships have contributed to the advancement of his research and the development of innovative pharmaceutical solutions.
Conclusion
Yvan LeHuerou's work exemplifies the intersection of innovation and healthcare, particularly in the field of mental health treatment. His contributions through patents and collaborations continue to influence the pharmaceutical industry positively.